Biogen (BIIB) Approves $5B Buyback

Biogen (NASDAQ: BIIB) disclosed in an SEC filing:

On March 24, 2019, the Board of Directors of Biogen Inc. (the “Company”) authorized a program to repurchase up to $5.0 billion of the Company’s common stock (the “2019 Share Repurchase Program”). The 2019 Share Repurchase Program does not have an expiration date. All share repurchases under the 2019 Share Repurchase Program will be retired. The 2019 Share Repurchase Program is in addition to the approximately $1.7 billion remaining under the share repurchase program authorized by the Board of Directors of the Company in August 2018.

You May Also Be Interested In

• Cosmos Health buyback reaches 5.11 million shares at avg $0.2554
• AMR Resources prices $250M IPO on Nasdaq at $10 per unit
• DBV Technologies refreshes ATM program with $150M ADS offering